Added to YB: 2026-06-19
Pitch date: 2026-06-17
CAI [neutral]
Caris Life Sciences, Inc.
-13.76%
current return
Author Info
Company Info
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
Market Cap
$4.4B
Pitch Price
$18.17
Price Target
N/A
Dividend
N/A
EV/EBITDA
28.73
P/E
-8.68
EV/Sales
4.42
Sector
Biotechnology
Category
growth
Caris Life Sciences: the Deepest Data in Oncology
CAI (overview): Oncology genomics co reading whole exome (~23K genes) vs Tempus' 648-panel. Rev $216M Q1'26 (+79%), positive EBITDA/FCF—only self-funding comp. Tissue ASP ~$4,300. Bull: re-mineable corpus, AI signatures, pricing power. Bear: pharma data rev only $75-85M '26 vs Tempus' $316M—breadth winning commercially. Depth vs breadth experiment.
Read full article (7 min)